{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T14:27:23Z","timestamp":1777645643595,"version":"3.51.4"},"reference-count":43,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":4089,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1038\/modpathol.2011.106","type":"journal-article","created":{"date-parts":[[2011,6,24]],"date-time":"2011-06-24T08:45:52Z","timestamp":1308905152000},"page":"1488-1499","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":136,"title":["Tubal origin of \u2018ovarian\u2019 low-grade serous carcinoma"],"prefix":"10.1016","volume":"24","author":[{"given":"Jie","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nisreen","family":"Abushahin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shujie","family":"Pang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Setsuko K","family":"Chambers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oluwole","family":"Fadare","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beihua","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenxin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/modpathol.2011.106_bib1","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0140-6736(71)92335-X","article-title":"Incessant ovulation\u2013a factor in ovarian neoplasia?","volume":"2","author":"Fathalla","year":"1971","journal-title":"Lancet"},{"key":"10.1038\/modpathol.2011.106_bib2","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1093\/jnci\/84.8.592","article-title":"Spontaneous transformation of rat ovarian surface epithelial cells: association with cytogenetic changes and implications of repeated ovulation in the etiology of ovarian cancer","volume":"84","author":"Godwin","year":"1992","journal-title":"J Natl Cancer Inst"},{"key":"10.1038\/modpathol.2011.106_bib3","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S1470-2045(08)70308-5","article-title":"The cell of origin of ovarian epithelial tumours","volume":"9","author":"Dubeau","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1038\/modpathol.2011.106_bib4","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1200\/JCO.2008.16.4814","article-title":"Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention","volume":"26","author":"Carlson","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1038\/modpathol.2011.106_bib5","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/00000478-200202000-00003","article-title":"Unexpected gynecologic neoplasms in patients with proven or suspected BRCA-1 or -2 mutations: implications for gross examination, cytology, and clinical follow-up","volume":"26","author":"Agoff","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2011.106_bib6","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1200\/JCO.2007.12.2622","article-title":"Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction","volume":"25","author":"Callahan","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1038\/modpathol.2011.106_bib7","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.pas.0000213335.40358.47","article-title":"Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship","volume":"31","author":"Kindelberger","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2011.106_bib8","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1001\/jama.296.2.185","article-title":"Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation","volume":"296","author":"Finch","year":"2006","journal-title":"JAMA"},{"key":"10.1038\/modpathol.2011.106_bib9","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1097\/PAS.0b013e3181bc6059","article-title":"Multistep level sections to detect occult fallopian tube carcinoma in risk-reducing salpingo-oophorectomies from women with BRCA mutations: implications for defining an optimal specimen dissection protocol","volume":"33","author":"Rabban","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2011.106_bib10","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.molonc.2009.01.004","article-title":"Intercepting pelvic cancer in the distal fallopian tube: theories and realities","volume":"3","author":"Crum","year":"2009","journal-title":"Mol Oncol"},{"key":"10.1038\/modpathol.2011.106_bib11","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/PAS.0b013e3181cf3d79","article-title":"The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory","volume":"34","author":"Kurman","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2011.106_bib12","first-page":"151","article-title":"Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications","volume":"27","author":"Kurman","year":"2008","journal-title":"Int J Gynecol Pathol"},{"key":"10.1038\/modpathol.2011.106_bib13","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ygyno.2009.01.013","article-title":"Precursors to pelvic serous carcinoma and their clinical implications","volume":"113","author":"Folkins","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1038\/modpathol.2011.106_bib14","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1365-2559.2007.02938.x","article-title":"Tubal and ovarian pathways to pelvic epithelial cancer: a pathological perspective","volume":"53","author":"Jarboe","year":"2008","journal-title":"Histopathology"},{"key":"10.1038\/modpathol.2011.106_bib15","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/path.2091","article-title":"A candidate precursor to serous carcinoma that originates in the distal fallopian tube","volume":"211","author":"Lee","year":"2007","journal-title":"J Pathol"},{"key":"10.1038\/modpathol.2011.106_bib16","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1038\/modpathol.2010.119","article-title":"High-grade fimbrial-ovarian carcinomas are unified by altered p53, PTEN and PAX2 expression","volume":"23","author":"Roh","year":"2010","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2011.106_bib17","series-title":"Surface Epithelial Tumors of the Ovary","author":"Seidman","year":"2002"},{"key":"10.1038\/modpathol.2011.106_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcp.2006.06.024","article-title":"PAX genes: roles in development, pathophysiology, and cancer","volume":"73","author":"Lang","year":"2007","journal-title":"Biochem Pharmacol"},{"key":"10.1038\/modpathol.2011.106_bib19","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ygyno.2006.08.052","article-title":"Emerging roles for PAX8 in ovarian cancer and endosalpingeal development","volume":"104","author":"Bowen","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1038\/modpathol.2011.106_bib20","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1210\/en.2006-1054","article-title":"Congenital hypothyroid female pax8-deficient mice are infertile despite thyroid hormone replacement therapy","volume":"148","author":"Mittag","year":"2007","journal-title":"Endocrinology"},{"key":"10.1038\/modpathol.2011.106_bib21","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1097\/PAS.0b013e31816d71ad","article-title":"Expression of pax8 as a useful marker in distinguishing ovarian carcinomas from mammary carcinomas","volume":"32","author":"Nonaka","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2011.106_bib22","doi-asserted-by":"crossref","unstructured":"Tong GX, Devaraj K, Hamele-Bena D, et al. PAX8: a marker for carcinoma of Mullerian origin in serous effusions. Diagn Cytopathol 2010; e-pub ahead of print.","DOI":"10.1002\/dc.21426"},{"key":"10.1038\/modpathol.2011.106_bib23","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/PAS.0b013e3181da7687","article-title":"PAX8 reliably distinguishes ovarian serous tumors from malignant mesothelioma","volume":"34","author":"Laury","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2011.106_bib24","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1046\/j.1365-2559.2002.01352.x","article-title":"Value of mesothelial and epithelial antibodies in distinguishing diffuse peritoneal mesothelioma in females from serous papillary carcinoma of the ovary and peritoneum","volume":"40","author":"Attanoos","year":"2002","journal-title":"Histopathology"},{"key":"10.1038\/modpathol.2011.106_bib25","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1097\/00000478-199810000-00005","article-title":"Role of immunohistochemistry in distinguishing epithelial peritoneal mesotheliomas from peritoneal and ovarian serous carcinomas","volume":"22","author":"Ordonez","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2011.106_bib26","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/modpathol.3800471","article-title":"The diagnostic utility of immunohistochemistry and electron microscopy in distinguishing between peritoneal mesotheliomas and serous carcinomas: a comparative study","volume":"19","author":"Ordonez","year":"2006","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2011.106_bib27","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/onc.2009.402","article-title":"Primary ex vivo cultures of human fallopian tube epithelium as a model for serous ovarian carcinogenesis","volume":"29","author":"Levanon","year":"2009","journal-title":"Oncogene"},{"key":"10.1038\/modpathol.2011.106_bib28","first-page":"1238","article-title":"Differential expression of estrogen, progesterone, and epidermal growth factor receptors in normal, benign, and malignant human breast tissues using dual staining immunohistochemistry","volume":"144","author":"van Agthoven","year":"1994","journal-title":"Am J Pathol"},{"key":"10.1038\/modpathol.2011.106_bib29","doi-asserted-by":"crossref","first-page":"e10358","DOI":"10.1371\/journal.pone.0010358","article-title":"Genetic analysis of the early natural history of epithelial ovarian carcinoma","volume":"5","author":"Pothuri","year":"2010","journal-title":"PLoS One"},{"key":"10.1038\/modpathol.2011.106_bib30","doi-asserted-by":"crossref","first-page":"6915","DOI":"10.1158\/0008-5472.CAN-04-2067","article-title":"Mutations of BRAF and KRAS precede the development of ovarian serous borderline tumors","volume":"64","author":"Ho","year":"2004","journal-title":"Cancer Res"},{"key":"10.1038\/modpathol.2011.106_bib31","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/path.1817","article-title":"Different proportions of aneusomic cells in ovarian inclusion cysts associated with serous borderline tumours and serous high-grade carcinomas support different pathogenetic pathways","volume":"207","author":"Korner","year":"2005","journal-title":"J Pathol"},{"key":"10.1038\/modpathol.2011.106_bib32","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/00000478-200404000-00009","article-title":"Grading ovarian serous carcinoma using a two-tier system","volume":"28","author":"Malpica","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2011.106_bib33","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/jcb.240590928","article-title":"Pathology of ovarian cancer precursors","volume":"23","author":"Scully","year":"1995","journal-title":"J Cell Biochem Suppl"},{"key":"10.1038\/modpathol.2011.106_bib34","doi-asserted-by":"crossref","unstructured":"Auersperg N . The origin of ovarian carcinomas: a unifying hypothesis. Int J Gynecol Pathol 2011.","DOI":"10.1097\/PGP.0b013e3181f45f3e"},{"key":"10.1038\/modpathol.2011.106_bib35","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1365-2559.1995.tb01528.x","article-title":"p53 protein expression in putative precursor lesions of epithelial ovarian cancer","volume":"27","author":"Hutson","year":"1995","journal-title":"Histopathology"},{"key":"10.1038\/modpathol.2011.106_bib36","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/00004347-200110000-00006","article-title":"Expression of calretinin in human ovary, testis, and ovarian sex cord-stromal tumors","volume":"20","author":"Cao","year":"2001","journal-title":"Int J Gynecol Pathol"},{"key":"10.1038\/modpathol.2011.106_bib37","doi-asserted-by":"crossref","first-page":"5284","DOI":"10.1200\/JCO.2008.18.1107","article-title":"New insights into the pathogenesis of serous ovarian cancer and its clinical impact","volume":"26","author":"Levanon","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1038\/modpathol.2011.106_bib38","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/path.2739","article-title":"Secretory cell outgrowth, PAX2 and serous carcinogenesis in the Fallopian tube","volume":"222","author":"Chen","year":"2010","journal-title":"J Pathol"},{"key":"10.1038\/modpathol.2011.106_bib39","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1093\/jnci\/95.6.484","article-title":"Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma","volume":"95","author":"Singer","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1038\/modpathol.2011.106_bib40","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1006\/gyno.2000.6066","article-title":"K-ras mutations in Mullerian inclusion cysts associated with serous borderline tumors of the ovary","volume":"80","author":"Alvarez","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1038\/modpathol.2011.106_bib41","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s004280050314","article-title":"In serous ovarian neoplasms the frequency of Ki-ras mutations correlates with their malignant potential","volume":"434","author":"Haas","year":"1999","journal-title":"Virchows Arch"},{"key":"10.1038\/modpathol.2011.106_bib42","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.ygyno.2006.05.029","article-title":"KRAS and BRAF mutations in ovarian tumors: a comprehensive study of invasive carcinomas, borderline tumors and extraovarian implants","volume":"103","author":"Mayr","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1038\/modpathol.2011.106_bib43","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/path.1521","article-title":"In ovarian neoplasms, BRAF, but not KRAS, mutations are restricted to low-grade serous tumours","volume":"202","author":"Sieben","year":"2004","journal-title":"J Pathol"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/modpathol2011106.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol2011106","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222028010?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222028010?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol2011106.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T01:03:27Z","timestamp":1760231007000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222028010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":43,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0893395222028010"],"URL":"https:\/\/doi.org\/10.1038\/modpathol.2011.106","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tubal origin of \u2018ovarian\u2019 low-grade serous carcinoma","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/modpathol.2011.106","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2011 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}